• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

The Pharmaceutical Market: Slovenia

  • ID: 3229956
  • April 2015
  • Region: Slovenia
  • 96 Pages
  • Espicom Business Intelligence Ltd

FEATURED COMPANIES

  • GlaxoSmithKline (GSK)
  • Krka
  • Lek (Novartis/Sandoz)
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

Overview Of The Pharmaceutical Market In Slovenia:

Slovenia's healthcare system is relatively developed and effective, particularly compared with other markets in Central and Eastern Europe. The country's health system faces short-term challenges as a result of austerity budgets which will limit public spending on healthcare and are designed to reduce the number of services covered under compulsory health insurance. Long-term threats concern the availability of public funds in a tightening economic and fiscal environment and projected rises in age-related health expenditure.

Headline Expenditure Projections:

Pharmaceuticals: EUR762mn (US$1.06mn) in 2011 to EUR769mn (US$977mn) in 2012; +1.0% in local currency terms and -7.8% in US dollar terms.

Healthcare: EUR3.40bn (US$4.73bn) in 2011 to EUR3.42bn (US$4.34bn) in 2012; 0.5% in local currency terms and -8.2% in US dollar terms.

Medical Devices: EUR235mn (US$327mn) in 2011 to EUR239mn (US$304mn) in 2012; +1.5% in local currency terms and -7.3% in US dollar terms.

Risk/Reward Rating:

In our Q1 13 assessment, we have revised downward our Pharmaceuticals and Healthcare Risk/Reward Ratings (RRRs) READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • GlaxoSmithKline (GSK)
  • Krka
  • Lek (Novartis/Sandoz)
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

1. SWOT

2. Political

3. Economic

4. Business Environment

5. Industry Forecast

6. Pharmaceutical Market Forecast

7. Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2010-2018)

8. Healthcare Market Forecast

- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2010-2018)
- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2010-2018)
- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2010-2018)

9. Prescription Drug Market Forecast

- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2010-2018)

10. Patented Drug Market Forecast

- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2010-2018)

11. Generic Drug Market Forecast

- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2010-2018)

12. OTC Medicine Market Forecast

- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2010-2018)

13. Pharmaceutical Trade Forecast

- Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2012-2018)
- Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2012-2018)

14. Key Risks To The Forecast Scenario

15. Macroeconomic Forecasts

16. Economic Analysis

17. Real GDP By Expenditure Breakdown

18. Risks To Outlook

- Table: Economic Activity (Slovenia 2009-2018)

19. Industry Risk Reward Ratings

20. Central And Eastern Europe Risk/Reward Ratings

21. Slovenia Risk/Reward Ratings

22. Rewards

23. Risks

24. Market Overview

25. Industry Trends And Developments

26. Epidemiology

27. Healthcare Sector

28. Research & Development

29. Regulatory Development

30. Intellectual Property Regime

31. Pricing Regime

32. Reimbursement Regime

33. Competitive Landscape

34. Pharmaceutical Industry

35. Recent Pharmaceutical Industry Developments

36. Company Profile

- Krka
- Lek (Novartis/Sandoz)
- GlaxoSmithKline (GSK)
- Sanofi
- Pfizer
- Novartis
- Merck & Co

37. Demographic Forecast

- Table: Slovenia's Population By Age Group, 1990-2020, 1990-2020 ('000)
- Table: Slovenia's Population By Age Group, 1990-2020 (% of total)
- Table: Slovenia's Key Population Ratios, 1990-2020
- Table: Slovenia's Rural And Urban Population, 1990-2020

38. Glossary

39. Methodology

40. Pharmaceutical Expenditure Forecast Model

41. Healthcare Expenditure Forecast Model

42. Notes On Methodology

43. Risk/Reward Index Methodology

44. Index Overview

- Table: Pharmaceutical Risk/Reward Index Indicators

45. Indicator Weightings

Note: Product cover images may vary from those shown

- GlaxoSmithKline (GSK)
- Krka
- Lek (Novartis/Sandoz)
- Merck & Co
- Novartis
- Pfizer
- Sanofi

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

AbbVie Ltd. Sigma-Aldrich Corporation Bruker Corporation Raumedic AG Ferring Pharmaceuticals B.V. Baxter International Inc.